Metastatic cancers: Targeting a protein that fuels treatment-resistant tumors may be key to ...
One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, ...
Pharm Exec50 分钟
FDA Approves Expanded Label for Roche's Companion Diagnostic to Identify HER2-Ultralow ...
The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...